MD Bioalpha Co., Ltd.
Records under this name other than patents MD Bioalpha Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to MD Bioalpha Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,066,922 | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases Formerly held Term ended Term ended Feb 15, 2026 · From the USPTO record | Term ended | Term ended Feb 15, 2026 | From the USPTO record |
| US 8,029,832 | Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity Formerly held Lapsed on the fee record Ended Oct 4, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2023 | From the USPTO record |
| US 8,466,141 | Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases Formerly held Lapsed on the fee record Ended Jun 18, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 18, 2021 | From the USPTO record |
| US 7,375,243 | Method for preparation of amino acid chelate Formerly held Lapsed on the fee record Ended May 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 20, 2020 | From the USPTO record |
| US 7,901,716 | Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng Formerly held Lapsed on the fee record Ended Mar 8, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2019 | From the USPTO record |